Loading Events

NIH: Technology Development and Commercialization Partnership Opportunities

Tuesday, May 23, 2023
Virtual – Zoom

Join The National Institutes of Health (NIH) for a virtual event, outlining the organization’s role as a Technology Development and Commercialization Partner.

The National Institutes of Health (NIH) is a resource that companies should consider to bolster their pipeline or solve a development problem. Attendees of this event will learn:

  • Who we are. The NIH is more than academic/basic research and SBIRs. Technology commercialization and economic development is part of our mission.
  • That companies, entrepreneurs, and other buy-side stakeholders – not just academia – can partner with the NIH
  • Why industry partnerships are mutually beneficial for companies and the NIH
  • How companies have worked with the NIH (success stories and partnership examples)
  • Next steps – points of contact, partnering mechanisms, licensing

The presenter will be Dr. Michael Salgaller, Supervisory Technology Analysis and Marketing Specialist at National Institutes of Health/National Cancer Institute.


Watch a recording of the full event HERE. This recording will be available for up to 30 days. Passcode: ^i=#2ty^

Access a full presentation summary HERE.

About Dr. Michael Salgaller

Dr. Michael Salgaller leads the Technology Analysis and Marketing Unit (TAMU) within the National Institutes of Health (NIH’s) Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. The TAMU serves in a business development role to foster licensing and collaborative activity between buy-side stakeholders and the NCI (as well as NIH in general). Immediately prior to returning to the NCI, Michael was a Vice President with a healthcare-focused government affairs firm, where he led alliance development activities centered on civilian health. Michael spent several years on the investment team of an early-stage venture capital firm dedicated to the life sciences. He began his career as a Senior Scientist at the NCI. He is the author of “Biotechnology Entrepreneurship,” and teaches an entrepreneurship class at NIH. Dr. Salgaller received his PhD in Pathology from The Ohio State University.